Global Next Generation Sequencing for Non-invasive Prenatal Testing Market Analysis and Prediction by Leading Manufacturers, its Application and Types

Global Next Generation Sequencing for Non-invasive Prenatal Testing Market 2023″ report provides 360° view on Industry by shading light on all major factors like Key Players, Demand for Products, End User & Applications, Future Growth & Forecast.

Non-Invasive Prenatal Testing (NIPT) is a type of testing method which is used to screen pregnancy for the risk of being affected with the most common chromosomal conditions such as Trisomy 21 (Down’s Syndrome), Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome). It is available to all pregnant women from 9 to 10 weeks of gestation, who are at both low-risk and high-risk for chromosomal aneuploidies. This test carries no risk of miscarriage and it is the most accurate screening test. The detection rate is more than 99% accurate.

NIPT is performed on a blood sample of the pregnant woman. The cell-free fetal DNA (cffDNA) which exceeds 4% of all the cell-free DNA in nearly all women from 10 weeks onward is collected and analyzed using next generation sequencing technology, coupled with advanced bioinformatics analysis. In addition to screening for common chromosomal trisomy conditions, few NIPT tests offer analysis of the X and Y sex chromosomes and gender identification. NIPT also screens for the risk of sex aneuploidy conditions including Turner’s (Monosomy X), Klinefelter (XXY) and Triple-X (XXX).

Download a PDF Sample of this Report @ http://www.orbisresearch.com/contacts/request-sample/2309290

The companies/laboratories currently offering NIPT screening across the world include:

– Ariosa (USA): Harmony.

– BGI Health (China): NIFTY.

– Illumina (USA): Verifi.

– Natera (USA) Panorama.

– Premaitha (UK): IONA.

– Sequenom (USA): MATERNIT21 PLUS.

Several NIPT methods have been developed based on recent advances in molecular biology and sequencing technologies. Recently, shotgun massively parallel sequencing (s-MPS) method is being commonly used for sequencing of DNA, after isolation and amplification of the cfDNA, which is followed by mapping the sequences to their chromosome and comparing the results.

Access the complete report with TOC & List of Tables @ http://www.orbisresearch.com/reports/index/next-generation-sequencing-for-non-invasive-prenatal-testing-global-insights

NIPT was first launched by commercial providers in the United States and China (Hong Kong) in 2011. It quickly moved into markets in Western Europe, the Middle East, South America, Asia and Africa, with samples from many of these countries being sent to the United States or China for testing. Studies show that adoption in developed countries is high and has significantly reduced the number of invasive tests performed.

Although NIPT is currently available through private providers, it is not yet widely available in publicly funded prenatal services. During the forecast period it is expected that even public service providers will adopt this test at a high rate.

Advantages offered by NIPT such as non-invasiveness, high accuracy and early detection. Coupled with raising awareness, increasing market penetration in Asia and Latin America and increase in average maternal age are the major factors expected to drive the growth of the global NIPT market during the forecast period.

Companies Mentioned:

  • 10X GENOMICS
  • 23ANDME
  • AGILENT TECHNOLOGIES, INC.
  • Annoroad
  • BERRY GENOMICS
  • BGI (Beijing Genomics Institute)
  • Eurofin GATC – Lifecodexx AG
  • Eurofins Gatc Biotech
  • ILLUMINA INC.
  • Knome, Inc. / Tute Genomics / Pierian Dx
  • LABCORP
  • Labcorp-sequenom Laboratories
  • NATERA, INC.
  • NIPD GENETICS
  • OXFORD NANOPORE TECHNOLOGIES LTD.
  • Pacific Biosciences Of California
  • PERKINELMER, INC.
  • Pieriandx, Inc.
  • PREMAITHA HEALTH PLC
  • QIAGEN NV
  • ROCHE HOLDING AG
  • THERMO FISHER SCIENTIFIC INC.

Enquiry before buying report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/2309290

Table of Content

Chapter 1 Introduction

Study Goals and Objectives

Reasons for Doing This Study

Scope of Report

Information Sources

Intended Audience

Methodology

Geographic Breakdown

Analyst’s Credentials

Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Next Generation Sequencing Overview

Technology Background

Structure and Importance of DNA

Genetic Variation and Analysis

Types of Genetic Variation

Genetic Analysis Technologies

DNA Sequencing Technologies

Whole Genome Sequencing

Targeted Resequencing

ChIP Sequencing

RNA Sequencing

Methylation Sequencing

History of DNA Sequencing

Sanger Sequencing

Introduction to Next-Generation Sequencing (NGS)

Roche 454 Pyrosequencing

Illumina Next-Generation Sequencing

Thermo Fisher Scientific (Life Technologies) NGS

Sequencing Instruments

Benchtop Sequencers

Informatics Technologies

Factors driving NGS Market

Improvements in Clinical NGS Informatics

Growing Need for Better Diagnostics as Part of Molecular Diagnostics Trend

Shift towards Precision Medicine

Factors Restraining NGS Market

Lack of reimbursement coverage and coding

Other Clinical Sequencing Technology Challenges

Chapter 4 Next Generation Sequencing Applications

Drug Discovery/Personalized Medicine

Agriculture and Animal Research

Infectious Diseases/Diagnostics

Genetic Screening

Cancer

Cardiovascular Diseases

Food-Borne Illness

HLA-Typing

Immune Diseases

Metabolic Diseases

Neurological Disorders

Mendelian Disorders

Infectious Diseases

Reproductive Health

Chapter 5 Next Generation Sequencing Based Non-Invasive Prenatal Testing

NIPT-Introduction and Technology Overview

Other Conventional Prenatal Testing Methods

Advantages of NIPT

Positive Predictive Value

Implementation of NIPT Process

In-House Testing

As a Service

Factors Driving NIPT Market

Average Risk NIPT

Favorable Reimbursement

New Advances in Genomic Technologies

Preference for Non-invasive Techniques Over Invasive Methods

Patient Counseling and Awareness

Increasing Collaborations with Local Entities

Increasing Mean Maternal Age

Restraints

Legal and regulatory issues

Access to the Advancing Technologies

Fetal Cell NIPT Industry

Current Market Scenario

Cost of NIPT

Chapter 6 Market Breakdown by NIPT Methods

NGS-based NIPT

NGS Sequencers for NIPT

VeriSeq NIPT Solution

MiSeqDx

NextSeq 550x

NextSeq 550AR

Non-Invasive Prenatal Tests Available in Market

NIFTY

Verifi Prenatal Test

Panorama

MaterniT21

IONA Test

Bambni Test

InformaSeq

Prena Test

VisibiliT

Veracity

Chapter 7 NGS-NIPT End Users

By Disease Area

Down’s Syndrome

Edwards Syndrome (Trisomy 18)

Patau syndrome (Trisomy 13)

Turner Syndrome

Others

By Healthcare Setting

Diagnostic laboratories

Hospitals

Chapter 8 Market Breakdown by Region

North America

USA

Europe

Asia-Pacific

Rest of the World

Chapter 9 Patent Review

Patent Review by Year

Chapter 10 Analysis of Market Opportunities

Market Share Analysis

PEST Analysis

Political

Economical

Social

Technological

Chapter 11 Competitive Landscape

Mergers and Acquisitions

New Product Launches

Agreements, Collaborations, and Partnerships

Chapter 12 Company Profiles

10X GENOMICS

Business Overview

Financials

Products and Services

23ANDME

Business Overview

Products and Services

AGILENT TECHNOLOGIES, INC.

Business Overview

Financials

Products and Services

Business Highlights

ANNOROAD

Business Overview

Products and Services

BERRY GENOMICS

Business Overview

Products and Services

BGI (BEIJING GENOMICS INSTITUTE)

Business Overview

Products and Services

Business Highlights

EUROFINS GATC BIOTECH

Business Overview

EUROFIN GATC – LIFECODEXX AG

Business Overview

Products and Services

Business Highlights

ILLUMINA INC.

Business Overview

Financials

Products and Services

Business Highlights (2017-2018)

KNOME, INC. / TUTE GENOMICS / PIERIAN DX

Business Overview

PIERIANDX, INC.

Products and Services

LABCORP-SEQUENOM LABORATORIES

Business Overview

LABCORP

Business Overview

Labcorp’s Businesses

Financials

Products and Services

NATERA, INC.

Business Overview

Financials

Products and Services

Business Highlights

NIPD GENETICS

Business overview

OXFORD NANOPORE TECHNOLOGIES LTD.

Business Overview

Financials

Products and Services

PACIFIC BIOSCIENCES OF CALIFORNIA

Business Overview

Financials

Products and Services

Business Highlights

PERKINELMER, INC.

PREMAITHA HEALTH PLC

Business Overview

Financials

Products and Services

Business Highlights

QIAGEN NV

Business Overview

Financials

Net Sales by Geographic Region

Products and Services

Business Highlights

ROCHE HOLDING AG

Business Overview

Financials

Products and Services

Historic Mergers and Acquisitions

THERMO FISHER SCIENTIFIC INC.

Business Overview

Financials

Products and Services

Business Highlights

 

About Orbis Research

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.